Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
Dendritic cells (DCs) possess the specialized potential to present exogenously derived antigen to cytotoxic T lymphocytes to elicit an immune response. This process, termed cross presentation, is crucial in the generation of immune response to viruses, tumors and in autoimmune disease. The ability o...
Main Authors: | Sachamitr, P, Fairchild, P |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2012
|
Registos relacionados
-
iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
Por: Horton, C, et al.
Publicado em: (2019) -
Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.
Por: Sachamitr, P, et al.
Publicado em: (2014) -
Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
Por: Sachamitr, P, et al.
Publicado em: (2018) -
Induced pluripotent stem cells: Challenges and opportunities for cancer immunotherapy
Por: Patty eSachamitr, et al.
Publicado em: (2014-04-01) -
STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy
Por: Nguyen Thi Nguyen, et al.
Publicado em: (2024-12-01)